Abstract
The classical studies of Huggins and Hodges (1) in which they reported the palliation of metastasing prostatic carcinoma by estrogens heralded a new era in the hormonal management of neoplastic disorders. This innovative work led directly to advances in the treatment of breast cancer and, to a lesser extent, in the arrest of malignant diseases of the adrenal and thyroid. Of similar importance in the historical context was the later work of Jensen and Jacobsen (2) on the specificity of the uptake and retention of tritiated estradiol-173 in rat uterus which, together with the advent of radioactive precursors for macromolecular syntheses, initiated a more penetrating and enterprising investigation of the mechanism of action of steroid hormones. Striking progress has been made in describing the selective binding processes or receptor systems for steroids and the mechanisms through which hormonal regulation may be expressed at a molecular level (3). It is propitious to appraise critically the impact and relevance of these experimental studies on the clinical management of prostatic carcinoma, particularly in the present economic climate where resources and finances are at a premium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Huggins, C. and C.V. Hodges, Cancer Res. 1:293, 1941.
Jensen, E.V. and H.I. Jacobsen, Recent Progr. Hormone Res. 18:387, 1962.
King, R.J.B. and W.I.P. Mainwaring, Steroid-Cell Interactions, Butterworths, London, 1974.
Harns, G.W. and B.T. Donovan, The Pituitary Gland, Butter-worths, London, 1966.
Medical Research Council Subcommittee Findings, Br. Med. J. 2:355, 1967.
Veterans Administration Cooperative Urological Research Group, Surg. Gynec. Obstet. 124:1011, 1967.
Byar, D.P., Cancer 32:1126, 1972.
Blackhard, CE., R.P. Doe and G.T. Mellinger, Cancer 26:249, 1970.
Blackhard, C.E. and G.T. Mellinger, Postgrad. Med., March Issue, 1972, p.140.
Editorial, Br. Med. J. 8:520, 1974.
Editorial, N.Z. Med. J. 14:113, 1974.
Robinson, M.R.G. and B.S. Thomas, Br. Med. J. 2:355, 1971.
Robinson, M.R.G., R.J. Shearer and J.D. Ferguson, Br. J. Urol. 46:555, 1974.
Moore, R.A., J. Urol. 33:24, 1935.
Chiu, CL. and D.L. Weber, J. Amer. Med. Assoc. 230:724, 1975.
Ashley, D.J.B., J. Pathol. Bacteriol. 90:217, 1965.
Doll, R., R. Payne and J. Waterhouse, Cancer Incidence in Five Continents, Springer-Verlag, Berlin, 1966.
Lytton, B., J.M. Emery and B.M. Harvard, J. Urol. 99:639, 1968.
Hospital Inpatient Enquiry 1970, London, Her Majesty’s Stationary Office, 1972.
Argyrose, S., J.P. Blandy, J.G. Gow, M. Singh, G.C. Tressider and J. Vinnicombe, Br. Med. J. 3:511, 1974.
Elton, J. and B.M. Wright, Br. Med. J. 3:808, 1974.
Geller, J., A. Angrist, K. Nakao and H. Newman, J. Amer. Med. Assoc. 210:1421, 1969.
Scott, W.W. and J.C. Wade, J. Urol. 101:81, 1969.
Hald, T. and A. From, Scand. J. Urol. Nephrol. 6:157, 1972.
Tveter, K.J., Acta Path. Microbiol. Scand. Sect. A., Suppl. 248:167, 1974.
Cowdrey’s Problems of Aging, A.I. Lansing (ed.), Third Edition, Springfield, C.C. Thomas & Co., 1952.
Raven, R.W., Cancer, Butterworths, London, 1957.
Kobayashi, T., J. Lobotsky and C.W. Lloyd, J. Clin. Endocrinol. Metab. 26:610, 1966.
Okamoto, M., C. Setaishi, Y. Horinch, K. Mashimo, K. Moriya and S. Ito, J. Clin. Endocrinol. Metab. 32:673, 1971.
Gomez, E.C. and S.L. Hsia, Biochemistry 7:24, 1968.
Eppenburger, U. and S.L. Hsia, J. Biol. Chem. 247:5463, 1973.
Adachi, K. and M. Kano, Steroids 20:567, 1972.
Mulay, S., R. Finkelberg, L. Pinsky and S.J. Solomon, J. Clin. Endocrinol. Metab. 34:133, 1972.
Keenan, B.S., W.J. Meyer, A.J. Hadjian and C.J. Migeon, Steroids 25:535, 1975.
Lowsley, O.M., Am. J. Surg. 8:526, 1930.
Fraaks, L.M., J. Pathol. Bact. 68:603, 1954.
McNeal, J. E., In: Pierrepoint, C.G. and K. Griffiths (eds.), Some Aspects of the Aetiology and Biochemistry of Prostatic Cancer, Alpha Press, Cardiff, 1970, p. 23.
Tannenbaum, M., Urology 4: 758, 1974.
Armenian, H.K., A.M. Lilienfield, E.L. Diamond and I.D.J. Bross, Lancet 2:115, 1974.
Williams, R.D. and CE. Blackhard, Lancet 2:1265, 1974.
Greenwald, P., V. Kirmss, A.K. Polan and V.S. Dick, J. Nat. Cancer Inst. 53:335, 1974.
Fraley, E.E., S. Ecker and M.M. Vincent, Science 170:340, 1970.
Sinha, A.A. and C.E. Blackhard, Urology 2:114, 1973.
Sommers, S.C., Cancer 10:345, 1957.
Marmorston, J., L.J. Lombardo, S.M. Myers, H. Gierson, H. Stern and CE. Hopkins, J. Urol. 93:276, 1965.
Frei, J.V., J. Nat. Cancer Inst. 54:524, 1975.
Thiessen, E.U., Cancer 34:1102, 1974.
Westphal, U., Steroid-Protein Interactions, Springer-Verlag, Berlin, 1971.
Pincus, C., In: Engels, E.T. and C Pincus (eds.), Hormones and the Aging Process, Academic Press, -New York, 1956, p. 1.
Kent, J.R. and A. B. Acone, In: Vermeulen, A. and D. Exley (eds.), Androgens in Normal and Pathological Conditions, Excerpta Medica, Amsterdam, 1966, p. 31.
Daughaday, W.H., J. Clin. Invest. 37:511, 1958.
Murphy, B.E.P., Canad. J. Biochem. 46:299, 1968.
Steeno, O., W. Heyns, H. Van Baelen and P. de Moor, Ann. En-docr. 29:141, 1968.
Dray, F., I. Mowszowicz, M.J. Ledru, O. Crépy, C Delzant and J. Sebaoun, Ann. Endocr. 30:223, 1969.
de Moor, P., O. Steeno, W. Heyns and H. Van Baelen, Ann. Endocr. 30:233, 1969.
Vermeulen, A., T. Stoica and L. Verdonck, J. Clin. Endocrinol. Metab. 33:759, 1971.
Ofner, P., Vit. Horm. 26:237, 1969.
Siiteri, P.K. and J.D. Wilson, J. Clin. Invest. 49:1737, 1970.
Mostofi, F.K., In: Campbell, M.F. and K.J. Harrison (eds.), Urology, W.B. Saunders & Co., Philadelphia, 1970, p. 1075.
Farnsworth, W.E., Invest. Urol. 8:367, 1971.
Gross, S.R., L. Aronow and W.B. Pratt, Biochem. Biophys. Res. Comm. 32:66, 1968.
Gross, S.R., L. Aronow and W.B. Pratt, J. Cell. Biol. 44: 103, 1970.
Wira, C. and Munck, A., J. Steroid Biochem. 5:810, 1974.
Williams, D. and J. Gorski, Biochem. Biophys. Res. Comm. 45: 258, 1971.
Milgrom, E., M. Atger and E.-E. Baulieu, Adv. Biosci. 7 : 235, 1971.
Giorgi, E.P., J.C. Stewart, J.K. Grant and I.M. Shirley, Biochem. J. 126:107, 1972.
Giorgi, E.P., I.M. Shirley, J.K. Grant and J.C. Stewart, Biochem. J. 132:465, 1973.
Giorgi, E.P., J.C. Stewart, J.K. Grant and R. Scott, Biochem. J. 123:41, 1971.
Harrison, R.W., S. Fairfield and D.N. Orth, Biochemistry 14: 1304, 1975.
Zuckerman, S. and J.R. Groome, J. Pathol. Bact. 44:113, 1937.
McNeal, J.E., Workshop on Benign Prostatic Hypertrophy, N.I.H., In Press.
Harper, M.E., C.G. Pierrepoint, A.R. Fahmy and K. Griffiths, J. Endocrinol. 49:213, 1971.
Evans, C.R. and G.C Pierrepoint, J. Endocrinol. 64:539, 1975.
Dunning, W.F., M.R. Curtis and A. Segaloff, Cancer Res. 6: 256, 1946.
Mirand, E.A. and W.J. Staubitz, Proc. Soc. Exp. Biol. Med. 93:451, 1956.
Aughey, E., R. Scott and I. McLaughlin, Br. J. Urol. 46: 561, 1974.
Brendler, H., Nat. Cancer Inst. Monogr. 12:343, 1963.
Chen, T.T. and C. Heidelberger, J. Nat. Cancer Inst, 42 : 915, 1969.
Fraley, E.E. and S. Ecker, J. Urol. 106:95, 1971.
Paulson, D.F., E.E. Fraley, J.B. DeKernion and A.S. Robson, Endocrinology 91: 396, 1972.
Cantifanto, Y.M., H.E. Kaufman and Z.S. Zam, J. Virol. 12: 1608, 1973.
Webber, M.M., O.G. Stonington and J. Lehman, Urology 1:561, 1973.
Pollard, M. and P.H. Luckert, J. Nat. Cancer Inst. 54:643, 1975.
Burrows, M.T., J.E. Burns and Y. Susuki, J. Urol. 1:3, 1917.
Pell, H.B. and R. Robinson, Biochem. J. 23:767, 1929.
Lasnitski, I., Nat. Cancer Inst. Monogr. 12:381, 1963.
Lasnitski, I., In: Pierrepoint, C.G. and K. Griffiths (eds.), Some Aspects of the Aetiology and Biochemistry of Prostatic Cancer, Alpha Press, Cardiff, 1970, p. 68.
Fraley, E.E. and D.F. Paulson, J. Urol. 101:735, 1969.
Schroeder, F.H. and S.J. Mackensen, Invest. Urol. 12:176, 1974.
Castro, J.E. and R.A. Sellwood, J. Path. Bact. 113:217, 1974.
McMahon, M.J., A.V.J. Butler and G.H. Thomas, Acta Endocrinol. (Copenh.) 77:784, 1974.
Harbitz, T.B., B. Falkanger and S. Sanger, Acta Path. Microbiol. Scand. Sect. A, Suppl. 248:89, 1974.
Webber, M.M., J. Ultrastruct. Res. 50:89, 1975.
McRae, C.V., R. Ghanadian, K. Fotherby and G.D. Chisholm, Er. J. Urol. 45:156, 1973.
Huggins, C. and P.S. Russell, Endocrinology 39:1, 1946.
Gunn, S.A., T.S. Gould and W.A.D. Anderson, J. Endocrinol. 32:205, 1965.
Grayhack, J.T. and J.M. Lebovitz, Invest. Urol. 5:87, 1967.
Lawrence, A.M. and R.L. Landau, Endocrinology 77:1119, 1965.
Farnsworth, W.E., In: Boyns, A.R. and K. Griffiths (eds.), Prolactin and Carcinogenesis, Alpha Press, Cardiff, 1972, p. 217.
Mawhinney, M.G., J.A. Belis, J.A. Thomas and J.W. Lloyd, J. Pharmacol. Exp. Ther. 192:242, 1975.
Asano, M., S. Kanzakim, E. Sekiguchi and T. Tasaka, J. Urol. 106:248, 1971.
Lostroh, A.J., Proc. Nat. Acad. Sci. U.S.A. 60:1312, 1968.
Fuller, D.J., K.M.B. Chan and G.H. Thomas, J. Endocrinol. 63:59P, 1974.
Hansson, V., K.J. Tveter, A. Attramadal and O. Torgerson, Acta Endocrinol. (Copenh.) 68:79, 1971.
Geller, J. and C. Worthman, Acta Endocrinol. (Copenh.) Suppl. 177:4, 1973
Rosen, V., I. Jung, E.-E. Baulieu and P. Robel, Compt. Rend. 248:4, 1975.
Mainwaring, W.I.P. and E.G.P. Milroy, J. Endocrinol. 57:371, 1973.
Steins, P., M. Kreig, H.J. Hollmann and K.D. Voigt, Acta Endocrinol. (Copenh.) 75:773, 1974.
Mobbs, B.G., I.E. Johnson and J.G. Connolly, J. Steroid Biochem. 6:453, 1975.
Mobbs, B.G., I.E. Johnson and J.G. Connolly, Urology 3: 105, 1974.
Wittlif, J.L., Seminars in Oncology 1:109, 1974.
Leclercq, G., J.C. Heusen, M.C. Deboel and W.H. Matteiem, Br. Med. J. 1:189, 1975.
McGuire, W.L., P.P. Carbone, M.E. Sears and G.C. Escher, In: McGuire, W.L., P.P. Carbone and E.P. Vollmer (eds.), Estrogen Receptors in Human Breast Cancer, Raven Press, New York, 1975, p.110.
Orestano, F., J.E. Altwein, P. Knapstein and K. Bandhauer, J. Steroid Biochem. 6:845, 1975.
Voigt, K. and S.L. Hsia, Endocrinology 92:1216, 1973.
Hisaeter, P.A., Invest. Urol. 12:33, 1974.
Muntzing, J., S.K. Shukla, T.M. Chu, A. Mittelman and G.P. Murphy, Invest. Urol. 12:65, 1974.
Boris, A., J.W. Scott, L. de Martino and D.C. Cox, Acta Endocrinol. (Copenh.) 72:604, 1973.
Neri, R. and M. Monahan, Invest. Urol. 10:123, 1972.
Neri, R., K. Florance, P. Koziol and S. van Cleave, Endocrinology 9:427, 1972.
Mainwaring, W.I.P., F.R. Mangan, P.A. Feherty and M. Friefeld, Mol. Cell. Endocrinol. 1:113, 1974.
Varkarakis, M.J., R.Y. Kirdani, H. Yamanaka, G.P. Murphy and A.A. Sandberg, Invest. Urol. 12:275, 1975.
Rann, F., Kastrationens betydning i prostata hypertrofiens behandling, H. Aschehoug and Co., Kristiania, 1894.
White, J.W., Ann. Surg. 22:1, 1895.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Mainwaring, W.I.P. (1976). The Relevance of Studies on Androgen Action to Prostatic Cancer. In: Menon, K.M.J., Reel, J.R. (eds) Steroid Hormone Action and Cancer. Current Topics in Molecular Endocrinology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2601-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2601-4_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2603-8
Online ISBN: 978-1-4684-2601-4
eBook Packages: Springer Book Archive